The TAPUR trial family: a global data sharing platform
The TAPUR trial family: a global data sharing platform
Biobanking and early diagnosis to defeat NSCLC
Patients access to precision oncology
Early development in oncology: Are the MTD and monotherapy efficacy still the best objectives?
U.S. National Cancer Institute perspective on precision oncology
WINTHER & SPRING: Targeted agents and triple agent combinations
Implementing precision medicine in oncology: The IMPACT trials
Lessons from long-term survey of stage I NSCLC
The latest understanding of breakthrough cancer pain management
Editor's Choice for June 2018
Expert insight: The basic medical understanding of neutropenia and general clinical considerations
MASCC 2018: Chemotherapy-induced neutropenia and the role of G-CSFs